| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/27/2010 | CN100584381C Medicinal composition containing sulfourea antidiabetic medicine and vitamine B |
| 01/27/2010 | CN100584332C Eye-drops preparations containing tetrandrine and its application for preparing medicine therewith |
| 01/27/2010 | CN100584331C Use of immunomudulatory compounds in preparing medicine for the treatment, control or prevention of myeloproliferative diseases |
| 01/27/2010 | CN100584324C Use of camostat in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 01/26/2010 | US7653495 Comprises series of steps including identifying cavity proximal to functional critical site, determining physical parameters of cavity, identifying functional groups which can be accommodated by cavity, testing compounds comprising such functional groups in an in vitro assay to determine which are active |
| 01/26/2010 | US7652135 Compositions useful as inhibitors of protein kinases |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652038 Methods of reducing angiogenesis |
| 01/26/2010 | US7652026 Pharmaceutical composition |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651855 Ex vivo activated; provide sufficient amounts of culture expanded isolated CD4+CD25+ suppressor Treg cells; long term suppressor capability; therapeutic prevention, blocking, inhibiting the rejection of transplanted tissue, protecting against graft vs host disease; donor cells allogeneically introduced |
| 01/26/2010 | US7651846 Treatment and diagnosis of conditions associated with elevated arginase activity |
| 01/26/2010 | US7651844 Method for screening agents capable of treating obesity |
| 01/26/2010 | US7651703 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 01/26/2010 | US7651461 Cardiac support with metallic structure |
| 01/26/2010 | CA2499354C Transcription control factor zhx3 |
| 01/26/2010 | CA2468748C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/26/2010 | CA2447099C Delivery of compounds for the treatment of migraine through an inhalation route |
| 01/26/2010 | CA2434731C Modular infusion device and method |
| 01/26/2010 | CA2422889C Method for the treatment of neurological and neuropsychological disorders |
| 01/26/2010 | CA2403686C Substituted piperidines as melanocortin receptor agonists |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2385974C Treating endometriosis or infertility or improving fertility |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2299470C Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 01/26/2010 | CA2230086C Method to improve the biological and antiviral activity of protease inhibitors |
| 01/26/2010 | CA2213500C Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/21/2010 | WO2010009028A1 Intranasal compositions comprising a decongestant and a corticosteroid |
| 01/21/2010 | WO2010008084A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | WO2010007361A1 Metered dose inhaler |
| 01/21/2010 | WO2010007034A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | WO2010006407A2 Thermal therapy for prevention and/or treatment of cardiovascular diseases and other ailments |
| 01/21/2010 | WO2009143403A8 Combination therapy for the management hypertension |
| 01/21/2010 | WO2009115652A3 Bitherapy and tritherapy used for treating an hiv-positive patient |
| 01/21/2010 | WO2009115160A3 Chewing composition and the use thereof |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | US20100016562 Reducing the immunogenicity of fusion proteins |
| 01/21/2010 | US20100016444 Methods and Compositions for Treating Mammalian Nerve Tissue Injuries |
| 01/21/2010 | US20100015247 Carrageenan based antimicrobial compositions |
| 01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015147 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside |
| 01/21/2010 | US20100015108 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 01/21/2010 | US20100015090 Administering a Hepatitis C virus NS3/4A protease inhibitor such as telaprevir and a cytochrome P450 monooxygenase inhibitor such as ritonavir |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2736311A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | CA2734135A1 Metered dose inhaler |
| 01/21/2010 | CA2730590A1 Intranasal compositions comprising a decongestant and a corticosteroid |
| 01/21/2010 | CA2730225A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/20/2010 | EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 01/20/2010 | EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/20/2010 | EP2144613A2 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 01/20/2010 | EP1663191B1 Composition comprising rosiglitazone and metformin |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/20/2010 | EP1513818B1 Heterocyclic inhibitors of vegfr-2 kinases |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1443970B1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/20/2010 | EP1313422B1 Non-hormonal vaginal contraceptive |
| 01/20/2010 | EP1059940B1 topical compositions comprising an alpha 1-adrenergic blocker FOR TREATING PAINFUL CONDITIONS OF THE ANAL REGION |
| 01/20/2010 | CN101628905A C-aryl glucoside SGLT2 inhibitors and method |
| 01/20/2010 | CN101628116A Pharmaceutical composition for treating herpes zoster |
| 01/20/2010 | CN101628115A Liquid medicine for treating empyrosis |
| 01/20/2010 | CN101628005A Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/20/2010 | CN100581586C A rapid-acting pharmaceutical composition |
| 01/20/2010 | CN100581551C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 01/20/2010 | CN100581550C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/20/2010 | CN100581544C Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 01/20/2010 | CN100581539C Effective component of hedyotis diffusa and method of preparing the same and application |
| 01/20/2010 | CN100581502C Human soft tissue filler for injection, and its preparation method |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649017 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648957 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes |
| 01/19/2010 | US7648826 Detecting CYP24 expression level as a marker for predisposition to cancer |
| 01/19/2010 | US7648716 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/19/2010 | US7648703 Combination of anti-EP-CAM antibody with a chemotherapeutic agent |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/19/2010 | CA2439268C Combination comprising a signal transduction inhibitor and an epothilone derivative |
| 01/19/2010 | CA2417971C Oil/fat composition |
| 01/19/2010 | CA2393466C Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2373093C Methods and compounds for inhibiting amyloid deposits |
| 01/19/2010 | CA2366911C Compositions for improving fertility |
| 01/19/2010 | CA2335107C Leptin-mediated gene-induction |
| 01/19/2010 | CA2183620C Sustained release composition |
| 01/19/2010 | CA2164517C Method of treating retained pulmonary secretions |
| 01/14/2010 | WO2010006225A1 Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010005012A1 Apolactoferrin-containing composition |
| 01/14/2010 | WO2010004816A1 Inhibitor of degranulation of mast cell |
| 01/14/2010 | WO2010003528A1 Medicament comprising dimethyl fumarate for treating an illness caused by parasites |
| 01/14/2010 | WO2010003308A1 The use of nitric oxide and signal transduction system thereof in preparing medicaments for targeted therapy of malignant tumors |
| 01/14/2010 | WO2009142731A3 Niacin and nsaid for combination therapy |